A Trump administration rule that would have required drugmakers to disclose wholesale drug prices in TV ads was rejected by a U.S. Court of Appeals when it upheld a ruling June 16 on behalf of several pharma giants. The case was brought by Thousand Oaks biotech heavyweight Amgen, Indianapolis multinational Eli Lilly, New Jersey pharma…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
